{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:24:27Z","timestamp":1779294267428,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017718","name":"Natural Science Foundation of Yichang City","doi-asserted-by":"publisher","award":["A22\\u20132\\u2013025"],"award-info":[{"award-number":["A22\\u20132\\u2013025"]}],"id":[{"id":"10.13039\/100017718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019490","name":"Yalong River Joint Fund","doi-asserted-by":"publisher","award":["2024AFD132"],"award-info":[{"award-number":["2024AFD132"]}],"id":[{"id":"10.13039\/501100019490","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.mrfmmm.2024.111894","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T16:26:19Z","timestamp":1732033579000},"page":"111894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["High expression of SLC34A2 contributes to chemoresistance of non-small cell lung cancer against gefitinib: The critical role of miR-124\u20133p"],"prefix":"10.1016","volume":"830","author":[{"given":"Chao","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzhen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrfmmm.2024.111894_bib1","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib2","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111894_bib3","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1200\/JCO.23.00864","article-title":"Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world","volume":"41","author":"Kamangar","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.653805","article-title":"High expression levels of CDK1 and CDC20 in patients with lung squamous cell carcinoma are associated with worse prognosis","volume":"8","author":"Deng","year":"2021","journal-title":"Front Mol. Biosci."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib5","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jtho.2016.08.142","article-title":"Comprehensive characterization of oncogenic drivers in asian lung adenocarcinoma","volume":"11","author":"Li","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib6","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/ijc.25854","article-title":"Large-scale integration of microarray data reveals genes and pathways common to multiple cancer types","volume":"128","author":"Dawany","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111894_bib7","doi-asserted-by":"crossref","first-page":"35960","DOI":"10.18632\/oncotarget.8482","article-title":"Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.mrfmmm.2024.111894_bib8","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.18632\/oncotarget.7071","article-title":"Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.mrfmmm.2024.111894_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.21873\/cgp.20116","article-title":"MicroRNAs as potential targets for therapeutic intervention with metastasis of non-small cell lung cancer","volume":"16","author":"Weidle","year":"2019","journal-title":"Cancer Genom. Proteom."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib10","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000190289","article-title":"Expression of MDR1 (multidrug resistance) gene and its protein in normal human kidney","volume":"77","author":"Ernest","year":"1997","journal-title":"Nephron"},{"key":"10.1016\/j.mrfmmm.2024.111894_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41420-024-01892-w","article-title":"NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence","volume":"10","author":"Zhen","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-022-00441-w","article-title":"MiR-124-3p impedes the metastasis of non-small cell lung cancer via extracellular exosome transport and intracellular PI3K\/AKT signaling","volume":"11","author":"Zhu","year":"2023","journal-title":"Biomark. Res"},{"key":"10.1016\/j.mrfmmm.2024.111894_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/biom11121878","article-title":"Characterization of SLC34A2 as a potential prognostic marker of oncological diseases","volume":"11","author":"Vlasenkova","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.mrfmmm.2024.111894_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317720212","article-title":"High expression of SLC34A2 is a favorable prognostic marker in lung adenocarcinoma patients","volume":"39","author":"Zhang","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12943-019-1028-9","article-title":"Circular RNA F-circSR derived from SLC34A2-ROS1 fusion gene promotes cell migration in non-small cell lung cancer","volume":"18","author":"Wu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111894_bib16","doi-asserted-by":"crossref","first-page":"10383","DOI":"10.1007\/s13277-016-4928-y","article-title":"The effects and mechanisms of SLC34A2 on tumorigenicity in human non-small cell lung cancer stem cells","volume":"37","author":"Jiang","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib17","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","article-title":"KEGG as a reference resource for gene and protein annotation","volume":"44","author":"Kanehisa","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"key":"10.1016\/j.mrfmmm.2024.111894_bib19","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/nar\/gku1179","article-title":"going forward","volume":"43","author":"Gene Ontology Consortium","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/11795549241254460","article-title":"The impact of baseline vitamin D level in patients receiving gefitinib-directed therapy for EGFR-mutant non-small-cell lung cancer","volume":"18","author":"Noronha","year":"2024","journal-title":"Clin. Med Insights Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib21","article-title":"\u03b2-Elemene Reverses Gefitinib Resistance in NSCLC Cells by Inhibiting lncRNA H19-Mediated Autophagy","volume":"17","author":"Zhang","year":"2024","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.mrfmmm.2024.111894_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155690","article-title":"Polyphyllin I ameliorates gefitinib resistance and inhibits the VEGF\/VEGFR2\/p38 pathway by targeting HIF-1a in lung adenocarcinoma","volume":"129","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.mrfmmm.2024.111894_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10142-023-00991-8","article-title":"MiR-124-3p inhibits tumor progression in prostate cancer by targeting EZH2","volume":"23","author":"Song","year":"2023","journal-title":"Funct. Integr. Genom."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib24","doi-asserted-by":"crossref","first-page":"1285799","DOI":"10.3389\/fphar.2023.1285799","article-title":"MiR-124-3p mediates gastric cancer cell ferroptosis induced by an anti-cancer drug polyphyllin I","volume":"14","author":"Zheng","year":"2023","journal-title":"Front Pharm."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41417-024-00762-y","article-title":"miR-124-3p and miR-194-5p regulation of the PI3K\/AKT pathway via ROR2 in medulloblastoma progression","author":"Wang","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jtho.2023.12.009","article-title":"CD74\/SLC34A2-ROS1 fusion variants involving the transmembrane region predict poor response to crizotinib in NSCLC independent of TP53 mutations","volume":"19","author":"Li","year":"2024","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib27","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/tox.24004","article-title":"Inhibition of miR-578 through SOCS2-dependent manner reverses gefitinib resistance in NSCLC cells","volume":"39","author":"Yang","year":"2024","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib28","article-title":"miR-196a upregulation contributes to gefitinib resistance through inhibiting GLTP expression","volume":"23","author":"Liu","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/carcin\/bgad028","article-title":"Solamargine enhanced gefitinib antitumor effect via regulating MALAT1\/miR-141-3p\/Sp1\/IGFBP1 signaling pathway in non-small cell lung cancer","volume":"44","author":"Tang","year":"2023","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrfmmm.2024.111894_bib30","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12349","article-title":"Cucurbitacin B enhances apoptosis in gefitinib resistant non\u2011small cell lung cancer by modulating the miR\u201117\u20115p\/STAT3 axis","volume":"24","author":"Yu","year":"2021","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib31","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/1759-7714.15314","article-title":"SLC34A2 promotes cell proliferation by activating STX17-mediated autophagy in esophageal squamous cell carcinoma","volume":"15","author":"Xu","year":"2024","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111894_bib32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/clinchem\/hvae008","article-title":"Mechanisms of resistance to tyrosine kinase inhibitors in ROS1 fusion-positive nonsmall cell lung cancer","volume":"70","author":"Zhao","year":"2024","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mrfmmm.2024.111894_bib33","article-title":"SLC34A2 promotes cancer proliferation and cell cycle progression by targeting TMPRSS3 in colorectal cancer","volume":"229","author":"Yang","year":"2022","journal-title":"Pathol. Res Pr."}],"container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510724000447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510724000447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:24:47Z","timestamp":1768965887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027510724000447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":33,"alternative-id":["S0027510724000447"],"URL":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2024.111894","relation":{},"ISSN":["1386-1964"],"issn-type":[{"value":"1386-1964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High expression of SLC34A2 contributes to chemoresistance of non-small cell lung cancer against gefitinib: The critical role of miR-124\u20133p","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2024.111894","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111894"}}